Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-06

Clinical Trial Update: Combined Intrathecal Morphine and Dexmedetomidine Analgesia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating intrathecal morphine with dexmedetomidine for postoperative pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Morphine (morphine)

Snippet

Sponsor: Assiut University | Conditions: Postoperative Pain | Phase 2, Phase 3 | Status: COMPLETED